Literature DB >> 10582908

In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates.

M Zarazaga1, Y Sáenz, A Portillo, C Tenorio, F Ruiz-Larrea, R Del Campo, F Baquero, C Torres.   

Abstract

Testing of susceptibility to 13 antibiotics was performed with 90 isolates of Lactobacillus, Leuconostoc, and Pediococcus. MICs at which 90% of the isolates tested were inhibited by HMR3647, erythromycin, and ciprofloxacin were 0.015, 0.125 and 32 microg/ml, respectively. The penicillin MIC was > or = 16 microg/ml against 26.2% of the studied Lactobacillus sp. isolates and 50% of Lactobacillus plantarum. HMR3647 showed excellent activity against these genera.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10582908      PMCID： PMC89613          DOI： 10.1128/AAC.43.12.3039

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  Isolation and characterization of a plasmid from Lactobacillus fermentum conferring erythromycin resistance.

Authors:  M Fons; T Hégé; M Ladiré; P Raibaud; R Ducluzeau; E Maguin
Journal:  Plasmid       Date:  1997       Impact factor: 3.466

2.  Pediococcus acidilactici pneumonitis and bacteremia in a pregnant woman.

Authors:  P S Sarma; S Mohanty
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

3.  Lactobacillus bacteremia and endocarditis.

Authors:  S Antony; S Dummer; C Stratton
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

4.  Septicemia caused by vancomycin-resistant Pediococcus acidilactici.

Authors:  C L Golledge; N Stingemore; M Aravena; D Joske
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

5.  Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species.

Authors:  J M Swenson; R R Facklam; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

6.  Characterization of plasmids and plasmid-borne macrolide resistance from Lactobacillus sp. strain 100-33.

Authors:  L A Rinckel; D C Savage
Journal:  Plasmid       Date:  1990-03       Impact factor: 3.466

7.  The normal Lactobacillus flora of healthy human rectal and oral mucosa.

Authors:  S Ahrné; S Nobaek; B Jeppsson; I Adlerberth; A E Wold; G Molin
Journal:  J Appl Microbiol       Date:  1998-07       Impact factor: 3.772

8.  Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: organism identification, antibiotic therapy, and case report.

Authors:  G Klein; E Zill; R Schindler; J Louwers
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Meningitis caused by vancomycin-resistant Leuconostoc sp.

Authors:  Y M Coovadia; Z Solwa; J van den Ende
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

10.  Identification and cloning of a plasmid-encoded erythromycin resistance determinant from Lactobacillus reuteri.

Authors:  L T Axelsson; S E Ahrné; M C Andersson; S R Ståhl
Journal:  Plasmid       Date:  1988-09       Impact factor: 3.466
View more
  12 in total

1.  Feasibility of Genome-Wide Screening for Biosafety Assessment of Probiotics: A Case Study of Lactobacillus helveticus MTCC 5463.

Authors:  S Senan; J B Prajapati; C G Joshi
Journal:  Probiotics Antimicrob Proteins       Date:  2015-12       Impact factor: 4.609

2.  Antibiotic resistance among cultured bacterial isolates from bioethanol fermentation facilities across the United States.

Authors:  Colin A Murphree; E Patrick Heist; Luke A Moe
Journal:  Curr Microbiol       Date:  2014-04-20       Impact factor: 2.188

3.  Antibiotic susceptibility profile of Pediococcus spp. from diverse sources.

Authors:  Varsha Singla; Surajit Mandal; Poonam Sharma; Santosh Anand; Sudhir Kumar Tomar
Journal:  3 Biotech       Date:  2018-11-17       Impact factor: 2.406

4.  Key Roles of Human Polymorphonuclear Cells and Ciprofloxacin in Lactobacillus Species Infection Control.

Authors:  Narcisa Mandras; Vivian Tullio; Pio Maria Furneri; Janira Roana; Valeria Allizond; Daniela Scalas; Giulio Petronio Petronio; Virginia Fuochi; Giuliana Banche; Anna Maria Cuffini
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

5.  Diversity and Probiotic Potential of Lactic Acid Bacteria Isolated from Horreh, a Traditional Iranian Fermented Food.

Authors:  Alireza Vasiee; Behrooz Alizadeh Behbahani; Farideh Tabatabaei Yazdi; Seyed Ali Mortazavi; Hamid Noorbakhsh
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

6.  Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.

Authors:  K T Luh; P R Hsueh; L J Teng; H J Pan; Y C Chen; J J Lu; J J Wu; S W Ho
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

7.  Antibiotic resistances of starter and probiotic strains of lactic acid bacteria.

Authors:  Anja S Hummel; Christian Hertel; Wilhelm H Holzapfel; Charles M A P Franz
Journal:  Appl Environ Microbiol       Date:  2006-11-22       Impact factor: 4.792

8.  Association of mutation patterns in GyrA and ParC genes with quinolone resistance levels in lactic acid bacteria.

Authors:  Shaoying Li; Zhen Li; Wan Wei; Chunyan Ma; Xiaomin Song; Shufen Li; Wenying He; Jianjun Tian; Xiaoyan Huo
Journal:  J Antibiot (Tokyo)       Date:  2014-09-10       Impact factor: 2.649

9.  Antibiotic susceptibility and heterogeneity in technological traits of lactobacilli isolated from Algerian goat's milk.

Authors:  Leila Bousmaha-Marroki; Ahmed Marroki
Journal:  J Food Sci Technol       Date:  2014-10-05       Impact factor: 2.701

10.  Isolation of Pediococcus acidilactici Kp10 with ability to secrete bacteriocin-like inhibitory substance from milk products for applications in food industry.

Authors:  Sahar Abbasiliasi; Joo Shun Tan; Tengku Azmi Tengku Ibrahim; Ramakrishnan Nagasundara Ramanan; Faezeh Vakhshiteh; Shuhaimi Mustafa; Tau Chuan Ling; Raha Abdul Rahim; Arbakariya B Ariff
Journal:  BMC Microbiol       Date:  2012-11-15       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.